Durham biotech makes $78M deal for Philly firm to boost platform for cancer treatment

The Durham-based biopharmaceutical firm is aiming to boost its pipeline of drugs designed to combat recurrent glioma – a form of brain cancer.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 8, 2021 Category: Pharmaceuticals Authors: Cameron Snipes Source Type: news